Get the Stockscreener App
8.51
2.85%
-0.25
After Hours:
8.93
0.42
+4.94%
Neuropace Inc stock is traded at $8.51, with a volume of 110.39K.
It is down -2.85% in the last 24 hours and down -23.61% over the past month.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
See More
Previous Close:
$8.76
Open:
$8.74
24h Volume:
110.39K
Relative Volume:
0.32
Market Cap:
$279.12M
Revenue:
$65.42M
Net Income/Loss:
$-32.96M
P/E Ratio:
-6.7008
EPS:
-1.27
Net Cash Flow:
$-19.87M
1W Performance:
-6.17%
1M Performance:
-23.61%
6M Performance:
-38.15%
1Y Performance:
+10.09%
1-Day Range:
$8.49
$8.78
1-Week Range:
$8.49
$9.125
52-Week Range:
$5.45
$18.98
Neuropace Inc Stock (NPCE) Company Profile
Name
Neuropace Inc
Sector
Industry
Phone
(650) 237-2700
Address
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Compare NPCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
8.51 | 287.31M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Initiated | H.C. Wainwright | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Mar-14-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Initiated | Leerink Partners | Outperform |
| Nov-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-24-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-22-23 | Initiated | Lake Street | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Jan-19-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-11-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-18-21 | Initiated | Robert W. Baird | Outperform |
| May-17-21 | Initiated | JP Morgan | Overweight |
| May-17-21 | Initiated | Morgan Stanley | Overweight |
| May-17-21 | Initiated | SVB Leerink | Outperform |
| May-17-21 | Initiated | Wells Fargo | Overweight |
View All
Neuropace Inc Stock (NPCE) Latest News
Is NeuroPace Inc. a growth stock or a value stockEntry Signal Planner To Watch Now - jammulinksnews.com
What makes NeuroPace Inc. stock price move sharplyFinancial News Entry Points Backed By Experts - jammulinksnews.com
Published on: 2025-07-30 18:03:00 - metal.it
NeuroPace Inc. Earnings Report Breakdown: What Investors Should KnowPattern Alert With ROI Driven Strategy Shared - metal.it
Essex Investment Management Co. LLC Invests $1.70 Million in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
Why NeuroPace Inc. stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - beatles.ru
Legato Capital Management LLC Purchases Shares of 41,107 NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025 - 富途牛牛
How Efficient Is NeuroPace Inc. at Controlling Operating CostsReal Trader Watchlist of Hot Stocks Released - metal.it
What risks could impact NeuroPace Inc. stock performanceEarnings Play Trade Plan With Alerts Shared - metal.it
Should I hold or sell NeuroPace Inc. stock in 2025Market Forecast Alerts Backed By Experts - jammulinksnews.com
What markets is NeuroPace Inc. expanding into Is JKHY stock a good long term investment optionBeginner Investor Planner For Fast Growth - jammulinksnews.com
What institutional investors are buying NeuroPace Inc. stockInvest confidently with real-time market updates - jammulinksnews.com
When is NeuroPace Inc. stock expected to show significant growthAchieve rapid capital gains with smart investing - jammulinksnews.com
Is it the right time to buy NeuroPace Inc. stockBuild a portfolio that outperforms the market - jammulinksnews.com
Does NeuroPace Inc. stock perform well during market downturnsBuild wealth steadily with expert advice - jammulinksnews.com
How does NeuroPace Inc. compare to its industry peersHigh-performance stocks for savvy investors - jammulinksnews.com
How does NeuroPace Inc. generate profit in a changing economyBreakneck growth rates - jammulinksnews.com
Is NeuroPace Inc. stock overvalued or undervaluedInvest confidently with professional market insights - jammulinksnews.com
How volatile is NeuroPace Inc. stock compared to the marketHigh-impact investment strategies - jammulinksnews.com
What is the dividend policy of NeuroPace Inc. stockGame-changing capital returns - jammulinksnews.com
NeuroPace Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Access to Investment Community - beatles.ru
What are NeuroPace Inc. company’s key revenue driversDiscover breakthrough trading strategies - jammulinksnews.com
What are the latest earnings results for NeuroPace Inc.Unlock powerful insights from market experts - jammulinksnews.com
How NeuroPace Inc. stock performs during market volatilityFree Deep Market Trend Analysis - Newser
Does NeuroPace Inc. stock pay reliable dividendsFree Signals Group - Newser
NeuroPace Inc. Stock Analysis and ForecastOutstanding risk-reward balance - PrintWeekIndia
Is NeuroPace Inc. a good long term investmentTremendous growth opportunities - Autocar Professional
What analysts say about NeuroPace Inc. stockExceptional financial outcomes - PrintWeekIndia
What drives NeuroPace Inc. stock priceFree Trading Strategy Suggestions - PrintWeekIndia
Neurological Implants Market is projected to reach US$ 12.39 - openPR.com
Neuropace Inc Stock (NPCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):